Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$501K Buy
3,292
+1,498
+84% +$250K 0.02% 627
2026
Q1
$376K Sell
1,794
-1,418
-44% -$356K 0.02% 668
2025
Q4
$913K Sell
3,212
-30
-0.9% -$9.38K 0.05% 334
2025
Q3
$1M Buy
3,242
+1,859
+134% +$582K 0.05% 255
2025
Q2
$435K Buy
1,383
+164
+13% +$47.3K 0.03% 425
2025
Q1
$320K Buy
1,219
+105
+9% +$28.4K 0.03% 402
2024
Q4
$291K Buy
1,114
+59
+6% +$14.9K 0.03% 406
2024
Q3
$246K Sell
1,055
-27
-2% -$5.54K 0.02% 400
2024
Q2
$218K Buy
+1,082
New +$195K 0.02% 413
2024
Q1
Sell
-1,326
Closed -$288K 474
2023
Q4
$288K Buy
+1,326
New +$227K 0.03% 355

Other funds holding PODD

Syon Capital's PODD Position: Q2 2026 in Review

Syon Capital increased its Insulet (PODD) stake by 84% in Q2 2026, buying an estimated $250K and bringing the position to 3,292 shares worth $501K. The position accounts for 0.02% of the portfolio, ranked #627.

Syon Capital first reported a position in PODD in Q4 2023 and has held it in 10 quarters since. The position peaked at $1M in Q3 2025. 730 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Syon Capital held 3,292 shares of Insulet worth $501K as of Q2 2026.
  • Syon Capital bought 1,498 Insulet shares in Q2 2026, an estimated $250K.
  • Insulet made up 0.02% of Syon Capital's portfolio in Q2 2026, its #627 holding.
  • Syon Capital first reported a position in Insulet in Q4 2023 and has held it in 10 quarters since.
  • Syon Capital's Insulet position peaked at $1M in Q3 2025.
  • 730 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.